Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Acta Pharmaceutica Sinica. B
|
January 1, 2026
Artificial intelligence for radiopharmaceutical and molecular imaging
Jinping Tao, Ling Liang, Siqi Hao, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 7, 2023
[<sup>177</sup>Lu]Lu-labeled anti-claudin-18.2 antibody demonstrated radioimmunotherapy potential in gastric cancer mouse xenograft models
Ziqing Zeng, Liqiang Li, Jinping Tao, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 5, 2025
Predicting <sup>177</sup>Lu-DOTATATE therapy response through immune microenvironment parameters in gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Ziqing Zeng, Zizhen Zhang, Qing Xie, et al.
Molecular Pharmaceutics
|
November 8, 2024
Novel Peptide-Based <sup>68</sup>Ga-Labeled Radiotracer for Preclinical Studies of TIM3 Expression
Jinping Tao, Fei Wang, Ziqing Zeng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
July 19, 2024
On the shoulder of ADC: The development of <sup>124</sup>I-IMMU-132, an iodine-124-labelled Trop-2-targeting molecular probe for micro-PET imaging
Ziqing Zeng, Yong Zheng, Xieqiao Yan, et al.
Bioconjugate Chemistry
|
February 20, 2025
[<sup>177</sup>Lu]Lu-XYIMSR-01: A Novel CAIX-Targeted Radiotherapeutic for Enhanced Treatment of Malignant Glioma
Jing Wang, Chengxue He, Rui Guo, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 16, 2024
Radioiodinated Nanobody immunoPET probe for in vivo detection of CD147 in pan-cancer
Xiaokun Ma, Teli Liu, Rui Guo, et al.
Molecular Pharmaceutics
|
June 4, 2024
A CAIX Dual-Targeting Small-Molecule Probe for Noninvasive Imaging of ccRCC
Chengxue He, Futao Liu, Jinping Tao, et al.
Science Advances
|
October 17, 2025
Targeting RRM2 with dual-modal theranostic smart nanoresponder overcomes osimertinib resistance and triggers immune remodeling in NSCLC
Jinyu Zhu, Kaihui Cui, Wenyuan Zhou, et al.
Molecular Pharmaceutics
|
January 25, 2024
Construction and Preclinical Evaluation of <sup>124</sup>I/<sup>125</sup>I-Labeled Antibody Targeting T Cell Immunoglobulin and Mucin Domain-3
Jinping Tao, Ziqing Zeng, Chengxue He, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Acta Pharmaceutica Sinica. B
|
January 1, 2026
Artificial intelligence for radiopharmaceutical and molecular imaging
Jinping Tao, Ling Liang, Siqi Hao, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 7, 2023
[<sup>177</sup>Lu]Lu-labeled anti-claudin-18.2 antibody demonstrated radioimmunotherapy potential in gastric cancer mouse xenograft models
Ziqing Zeng, Liqiang Li, Jinping Tao, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 5, 2025
Predicting <sup>177</sup>Lu-DOTATATE therapy response through immune microenvironment parameters in gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Ziqing Zeng, Zizhen Zhang, Qing Xie, et al.
Molecular Pharmaceutics
|
November 8, 2024
Novel Peptide-Based <sup>68</sup>Ga-Labeled Radiotracer for Preclinical Studies of TIM3 Expression
Jinping Tao, Fei Wang, Ziqing Zeng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
July 19, 2024
On the shoulder of ADC: The development of <sup>124</sup>I-IMMU-132, an iodine-124-labelled Trop-2-targeting molecular probe for micro-PET imaging
Ziqing Zeng, Yong Zheng, Xieqiao Yan, et al.
Bioconjugate Chemistry
|
February 20, 2025
[<sup>177</sup>Lu]Lu-XYIMSR-01: A Novel CAIX-Targeted Radiotherapeutic for Enhanced Treatment of Malignant Glioma
Jing Wang, Chengxue He, Rui Guo, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 16, 2024
Radioiodinated Nanobody immunoPET probe for in vivo detection of CD147 in pan-cancer
Xiaokun Ma, Teli Liu, Rui Guo, et al.
Molecular Pharmaceutics
|
June 4, 2024
A CAIX Dual-Targeting Small-Molecule Probe for Noninvasive Imaging of ccRCC
Chengxue He, Futao Liu, Jinping Tao, et al.
Science Advances
|
October 17, 2025
Targeting RRM2 with dual-modal theranostic smart nanoresponder overcomes osimertinib resistance and triggers immune remodeling in NSCLC
Jinyu Zhu, Kaihui Cui, Wenyuan Zhou, et al.
Molecular Pharmaceutics
|
January 25, 2024
Construction and Preclinical Evaluation of <sup>124</sup>I/<sup>125</sup>I-Labeled Antibody Targeting T Cell Immunoglobulin and Mucin Domain-3
Jinping Tao, Ziqing Zeng, Chengxue He, et al.
Page
of 1